SPyDiag
Comprehensive management of the kidney transplant patient, from diagnosis to therapy
BK virus nephropathy
Worldwide, the number of kidney transplants is on the rise, reaching almost 100,000 in 2023. BK nephropathy is a disease that can lead to renal graft failure and a return to dialysis. In the absence of antiviral treatment, early monitoring for BK polyomavirus (BKPyV) reactivation is essential to fine-tune immunosuppressive therapy. It is therefore important to detect BKPyV reactivation early, to increase the frequency of post-transplant screening, and to develop a specific treatment…
OUR PRODUCTS
SPyDiag technological innovation
SPyDiag uses a urine test to provide a rapid, early response to the detection of BK Virus. SpyDiag also offers comprehensive management of graft rejection, thanks to its specific treatment …
ABOUT SPyDiag
Research and development company
specialized in diagnostic and therapeutic innovation
Set up in Tours in early 2020, the company is developing antibodies for diagnostic and therapeutic purposes to combat viral infections…
Our Team
SPyDiag team
SPyDiag is a team of complementary talents and varied skills
Bertrand de Castelnau
HEC , CEO
Antoine Touzé
PhD, professor co-founder
Etienne Brochot
PharmD, PhD, professor co-founder
Pauline Gaboriaud
CSO co-founder
Isabelle Bourguin
PhD, co-founder
Edouard Sèche
PhD, co-founder
They trust us
Our partners
they trust us and they join SPyDiag adventure, find out more about our partners
We’re in the news
PRESS RELEASES
They’re talking about us in the press and media. Find out about all SPyDiag publications.